Search
for
Sort by
Research 31–60 of 775
- JAK1 Signaling Is Involved in the Induction of Mechanical Alloknesis in Atopic Dermatitis
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature
- The Effect of JAK Inhibitor on the Survival, Anagen Re-Entry, and Hair Follicle Immune Privilege Restoration in Human Dermal Papilla Cells
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- JAK Inhibitor Baricitinib in the Treatment of Oral Lichen Planus: A Case Report
- JAK inhibitor deuruxolitinib shows encouraging hair re-growth in alopecia areata
- 695 Selectively targeting JAK1 or JAK3 pathway is sufficient to reverse alopecia areata
- 1332 Janus kinase inhibitor increases hair growth by increasing beta-catenin activity in outer root sheath cells
- Dysregulation of Leukaemia Inhibitory Factor (LIF) Signalling Pathway by Supraphysiological Dose of Testosterone in Female Sprague Dawley Rats During Development of Endometrial Receptivity
- At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- A review of Janus kinase inhibitor use in scarring alopecia
- Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus
- 170 Forecasting Phase 3 Dose-Response for Abrocitinib, an Oral Janus Kinase 1 Selective Inhibitor, Using Investigator’s Global Assessment and Eczema Area and Severity Index
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Two cases of alopecia areata treated with ruxolitinib: a discussion of ideal dosing and laboratory monitoring
- Successful treatment of alopecia universalis with abrocitinib: a case report
- Treatment of moderate-to-severe alopecia areata in pre-adolescent children with baricitinib
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Successful treatment of concomitant alopecia universalis and Crohn’s disease with upadacitinib: A case report
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient